Health Committee on May 1st, 2008

Evidence of meeting #26 for Health in the 39th Parliament, 2nd Session. (The original version is on Parliament’s site, as are the minutes.) The winning word was information.

A recording is available from Parliament.

On the agenda

Post-Market Surveillance of Pharmaceutical Products

MPs speaking

Joy Smith
Robert Thibault
Christiane Gagnon
Judy Wasylycia-Leis
Patricia Davidson
Patrick Brown
Carolyn Bennett
Luc Malo
Lui Temelkovski
Ron Cannan
Susan Kadis

Also speaking

Michael Vandergrift  Director General, Policy, Planning and International Affairs Directorate, Health Products and Food Branch, Department of Health
Marc Berthiaume  Director, Marketed Pharmaceuticals and Medical Devices Bureau, Marketed Health Products Directorate, Health Products and Food Branch, Department of Health
Brent Fraser  Director, Drug Program Services Branch, Ontario Ministry of Health and Long-Term Care
Bruce Carleton  Senior Clinician Scientist, Child and Family Research Institute, BC Children's Hospital, University of British Columbia
David Lee  Director, Office of Patented Medicines and Liaison, Therapeutic Products Directorate, Department of Health
Barbara Law  Interim Director, Vaccine Preventable Diseases Prevention and Vaccine Safety, Public Health Agency of Canada

12:55 p.m.

Conservative

The Chair Conservative Joy Smith

It would be great if you could do that, and then I'll make sure everyone has it.

I'd like to thank you all for coming today. This concludes our study on post-market surveillance for today. We want to thank you, especially for all your time--and the miles of travel, Dr. Carleton--and for being here today. Thank you.

The meeting is adjourned.